Emerging data suggest that antiviral therapy in the third trimester can prevent immunoprophylaxis failure. To minimize fetal exposure to antiviral agents, antiviral therapy during pregnancy should ...

Other Late-Breaking Studies Focused on Antiviral Therapies The late-breaking antiviral therapy session also featured new data on long-acting methods of treating patients with virally suppressed HIV.

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...

Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to a systematic review and meta ...

If you get six or more cold sores per year, your doctor may recommend something called suppressive antiviral therapy, which involves taking an antiviral medication every day to reduce the number ...

Suppressing the ZNF638 protein tricks the body into attacking glioblastoma , a potential breakthrough in brain cancer therapy ...

CBA therapy of HIV (and possibly other pathogens ... There is a high demand, therefore, for new antiviral lead compounds and novel therapeutic concepts. In this Review, an original therapeutic ...

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...

Candidates for antiviral therapy include those who are in the immune clearance (hepatitis B e antigen [HBeAg]-positive) or reactivation (HBeAg-negative) phases. Hepatitis B & hepatocellular ...

NanoViricides, Inc. (the "Company") (www.nanoviricides.com) is a publicly traded (NYSE American, stock symbol NNVC) clinical stage company that is creating special purpose nanomaterials for antiviral ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.